Literature DB >> 2555163

PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes.

C Wasylyk1, P Flores, A Gutman, B Wasylyk.   

Abstract

We have found that the activity of the transcription factor PEA3 is regulated by the expression of non-nuclear oncogenes. This factor, although distinct from PEA1 (AP1), is activated by the same oncogenes (v-src, polyoma (Py) middle T, c-Ha-ras, v-mos, v-raf), by tetradecanoyl phorbol-acetate (TPA) and by serum components. We present evidence that PEA3 and PEA1 co-operate in the response of the polyoma virus (Py) alpha domain to oncogene expression. However, in contrast to PEA1, c-fos does not appear to be necessary for activation of PEA3, suggesting that PEA3 is a fos independent target for regulation of transcription by non-nuclear oncogenes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555163      PMCID: PMC401480          DOI: 10.1002/j.1460-2075.1989.tb08500.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone.

Authors:  S M Frisch; H E Ruley
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

2.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.

Authors:  S Green; I Issemann; E Sheer
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

3.  The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer.

Authors:  C Wasylyk; J L Imler; J Perez-Mutul; B Wasylyk
Journal:  Cell       Date:  1987-02-13       Impact factor: 41.582

4.  A gene activated by growth factors is related to the oncogene v-jun.

Authors:  K Ryder; L F Lau; D Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes.

Authors:  K Yoshida; L Venkatesh; M Kuppuswamy; G Chinnadurai
Journal:  Genes Dev       Date:  1987-09       Impact factor: 11.361

6.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

7.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

8.  A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum.

Authors:  J L Imler; C Schatz; C Wasylyk; B Chatton; B Wasylyk
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

9.  Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers.

Authors:  J Piette; M Yaniv
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers.

Authors:  R Rosales; M Vigneron; M Macchi; I Davidson; J H Xiao; P Chambon
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more
  72 in total

1.  Kinetic analysis of the steps of the polyomavirus lytic cycle.

Authors:  L Chen; M Fluck
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 2.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  A role for the ETS domain transcription factor PEA3 in myogenic differentiation.

Authors:  J M Taylor; E E Dupont-Versteegden; J D Davies; J A Hassell; J D Houlé; C M Gurley; C A Peterson
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Different binding site requirements for binding and activation for the bipartite enhancer factor EF-1A.

Authors:  G M Bolwig; J T Bruder; P Hearing
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

5.  Characterization of the promoter region of the src family gene lyn and its trans activation by human T-cell leukemia virus type I-encoded p40tax.

Authors:  F Uchiumi; K Semba; Y Yamanashi; J Fujisawa; M Yoshida; K Inoue; K Toyoshima; T Yamamoto
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

6.  Induction of the HPV16 enhancer activity by Jun-B and c-Fos through cooperation of the promoter-proximal AP-1 site and the epithelial cell type--specific regulatory element in fibroblasts.

Authors:  K Kikuchi; A Taniguchi; S Yasumoto
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

7.  Molecular organization of the human Raf-1 promoter region.

Authors:  T W Beck; U Brennscheidt; G Sithanandam; J Cleveland; U R Rapp
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

8.  Definition of functional domains in P135gag-myb-ets and p48v-myb proteins required to maintain the response of neuroretina cells to basic fibroblast growth factor.

Authors:  C Garrido; D Leprince; J S Lipsick; D Stehelin; D Gospodarowicz; S Saule
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

Authors:  Z Dong; M J Birrer; R G Watts; L M Matrisian; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

10.  Interaction of nuclear factor EF-1A with the polyomavirus enhancer region.

Authors:  G M Bolwig; P Hearing
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.